GUMDROP : A Randomized Gene Fusion Stratified Phase 2 Trial Of Abiraterone With Or Without ABT-888 For Patients With Metastatic Castration-Resistant Prostate Cancer

Created by Nancy Dawson, last modified on Apr 28, 2013
Description:This randomized phase II trial studies abiraterone acetate and prednisone together with veliparib to see how well it works compared to abiraterone acetate and prednisone alone in treating patients with metastatic hormone-resistant prostate cancer.
Link:http://clinicaltrials.gov/ct2/show/NCT01576172
Site:Johns Hopkins University
Principal Investigator:Emmanuel S. Antonarakis, MD